Use of antirheumatic drugs in mothers and fathers before and during pregnancy - A population-based cohort study

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 8, 2009, Pages 737-742

  Viktil, Kirsten K ^a,b   Engeland, Anders ^c,d   Furu, Kari ^c  

^a DIAKONHJEMMET HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d UNIVERSITY OF BERGEN   (Norway)

Author keywords

Antirheumatic drugs; Drug use; Expectant fathers; Pregnancy

Indexed keywords

ADALIMUMAB; ANTIRHEUMATIC AGENT; AZATHIOPRINE; ETANERCEPT; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE;

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EXPOSURE; DRUG USE; EXPECTANT FATHER; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTHER; NORWAY; POPULATION RESEARCH; PREGNANCY OUTCOME; PRESCRIPTION; PRIORITY JOURNAL; RHEUMATIC DISEASE; SECOND TRIMESTER PREGNANCY; TERATOGENICITY; THIRD TRIMESTER PREGNANCY; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; DRUG UTILIZATION; FATHER; FETUS; HEALTH SURVEY; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATION; REGISTER; RISK ASSESSMENT; STATISTICS; TIME;

ADOLESCENT; ADULT; ANTIRHEUMATIC AGENTS; COHORT STUDIES; DRUG PRESCRIPTIONS; DRUG UTILIZATION; DRUG UTILIZATION REVIEW; FATHERS; FEMALE; FETUS; HUMANS; MALE; MIDDLE AGED; MOTHERS; NORWAY; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS; REGISTRIES; RISK ASSESSMENT; TIME FACTORS; YOUNG ADULT;

EID: 70349766395     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1775     Document Type: Article

References (20)

1. Temprano KK, Bandlamudi R, Moore TL. Antirheumatic drugs in pregnancy and lactation. Semin Arthritis Rheum 2005; 35: 112-121. DOI:10.1016/j.semarthrit. 2005.05.002
2. Ostensen M, Khamashta M, Lockshin M, Parke A, Brucato A, Carp H, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 2006; 8: 209. DOI:10.1186/ar1957
3. Ostensen M, Lockshin M, Doria A, Valesini G, Meroni P, Gordon C, et al. Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs. Rheumatology 2008; 47 Suppl (3): iii28-iii31. DOI:10.1093/rheumatology/ken168
4. Schaefer C, Miller R. In Drugs During Pregnancy and Lactation, (2nd edn) Elsevier Press: San Diego,CA, 2007.
5. Neville CE, McNally J. Maternal exposure to leflunomide associated with blindness and cerebral palsy. Rheumatology 2007; 46: 1506. (Pubitemid 47317104)
6. Ostensen M, von Esebeck M, Villiger PM. Therapy with immunosuppressive drugs and biological agents and use of contraception in patients with rheumatic disease. J Rheumatol 2007; 34: 1266-1269. (Pubitemid 46898107)
7. Engeland A, Bramness JG, Daltveit AK, Ronning M, Skurtveit S, Furu K. Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006. Br J Clin Pharmacol 2008; 65: 653-660. DOI:10.1111/j.1365-2125.2008-03102.x
8. Bakker MK, Jentink J, Vroom F, Van Den Berg PB, De Walle HE, de Jong-van den Berg LT. Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands. BJOG 2006; 113: 559-568. DOI:10.1111/j.1471- 0528-2006.00927.x
9. Furu K. Establishment of the nationwide Norwegian Prescription Database (NorPD) - New opportunities for research in pharmacoepidemiology in Norway. Norsk Epidemiologi 2008; 18: 129-136. (Pubitemid 351859935)
10. Irgens LM. The medical birth registry of Norway. Epidemiological research and surveillance throughout 30 years. Acta Obstet Gynecol Scand 2000; 79: 435-439.
11. WHO Collaboratoring Centre for Drug Statistics Methodology. ATC classification index with DDDs. WHO Collaborating Centre, Oslo, 2008.
12. Uhlig T, Kvien TK, Glennas A, Smedstad LM, Forre O. The incidence and severity of rheumatoid arthritis, results from a county register in Oslo, Norway. J Rheumatol 1998; 25: 1078-1084. (Pubitemid 28350879)
13. Chambers C, Koren G, Tutuncu ZN, Johnson D, Jones KL. Are new agents used to treat rheumatoid arthritis safe to take during pregnancy? Organization of teratology information specialists (OTIS) study. Can Fam Physician 2007; 53: 409-412. (Pubitemid 46536564)
14. Chakravarty EF, Sanchez-Yamamoto D, Bush TM. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes. J Rheumatol 2003; 30: 241-246. (Pubitemid 36152584)
15. Vroom F, van Roon EN, van den Berg PB, Brouwers JR, de Jong-van den berg LT. Prescribing of sulfasalazine, azathioprine and methotrexate round pregnancy - A descriptive study. Pharmacoepidemiol Drug Saf 2008; 17: 52-61. DOI:10.1002/pds.1506.
16. Lande B, Andersen LF, Baerug A, Trygg KU, Lund-Larsen K, Veierod MB, et al. Infant feeding practices and associated factors in the first six months of life: the Norwegian infant nutrition survey. Acta Paediatr 2003; 92: 152-161. (Pubitemid 36390418)
17. Barrett JH, Brennan P, Fiddler M, Silman AJ. Does rheumatoid arthritis remit during pregnancy and relapse postpartum? Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy. Arthritis Rheum 1999; 42: 1219-1227. (Pubitemid 29268959)
18. Terslev L, Danneskiold-Samsoe B. Pregnancy in women with rheumatoid arthritis. Ugeskr Laeger 2003; 165: 3077-3081.
19. Beardon PH, McGilchrist MM, McKendrick AD, McDevitt DG, Mac- Donald TM. Primary non-compliance with prescribed medication in primary care. Br Med J 1993; 2: 846-848.
20. Hyrich KL, Symmons DP,Watson KD, Silman AJ. Pregnancy outcome in women who were exposed to anti-tumor necrosis factor agents: results from a national population register. Arthritis Rheum 2006; 54: 2701-2702.